Trials / Unknown
UnknownNCT05247515
Evaluation of Nexpowder Application to Prevent Delayed Bleeding After Colorectal Endoscopic Mucosal Resection
Evaluation of Nexpowder Application to Prevent Delayed Bleeding After Large Colorectal Endoscopic Mucosal Resection
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 304 (estimated)
- Sponsor
- Gabriel RAHMI · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
Delayed bleeding is the most frequent (5 to 15%) and challenging complication after large colorectal polypectomy. Different preventive treatments, such as the prophylactic use of clips, have been tried to prevent the occurrence of delayed bleeding, but to date, no treatment has clearly shown its effectiveness. In addition, preventive hemostasis with clips is difficult and costly. A newly developed endoscopic hemostatic powder generating gelation effect (Nexpowder) may be an effective alternative to prevent post polypectomy bleeding in patients treated by endoscopic mucosal resection (EMR) for large superficial colorectal lesions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Endoscopic mucosal resection with nexpowder | At the end of the EMR procedure, the patient will be randomized. In the treated group, Nexpowder will be sprayed thanks to a catheter inserted through the operating channel of the endoscope. |
Timeline
- Start date
- 2022-07-01
- Primary completion
- 2022-08-01
- Completion
- 2024-08-01
- First posted
- 2022-02-21
- Last updated
- 2022-02-21
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05247515. Inclusion in this directory is not an endorsement.